Grzegorz S Nowakowski, MD

Associate Professor

  • 3658 Citations
  • 37 h-Index
20012018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 40 Similar Profiles
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
B-Cell Chronic Lymphocytic Leukemia Medicine & Life Sciences
Follicular Lymphoma Medicine & Life Sciences
Survival Medicine & Life Sciences
Non-Hodgkin's Lymphoma Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
B-Cell Lymphoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2001 2018

  • 3658 Citations
  • 37 h-Index
  • 117 Article
  • 5 Review article
  • 3 Letter

A case of ibrutinib-associated aspergillosis presenting with central nervous system, myocardial, pulmonary, intramuscular, and subcutaneous abscesses

McCarter, S. J., Vijayvargiya, P., Sidana, S., Nault, A. M., Lane, C. E., Lehman, J., Wilson, J. W., Parikh, S. A., Nowakowski, G. S. & Al-Kali, A., Jan 1 2018, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Aspergillosis
Abscess
Central Nervous System
Lung
PCI 32765

Advances in CD30- and PD-1-targeted therapies for classical Hodgkin lymphoma

Wang, Y., Nowakowski, G. S., Wang, M. L. & Ansell, S. M., Apr 23 2018, In : Journal of Hematology and Oncology. 11, 1, 57.

Research output: Contribution to journalReview article

Hodgkin Disease
Programmed Cell Death 1 Receptor
Antibodies
Secondary Prevention
Radiotherapy

A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma

Padrnos, L., Ernst, B., Dueck, A., Kosiorek, H. E., Ginos, B. F., Toro, A., Johnston, P. B., Habermann, T. M., Leis, J. F., Mikhael, J. R., Nowakowski, G. S., Colgan, J., Porrata, L., Ansell, S. M., Witzig, T. E. & Reeder, C., Jan 1 2018, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Lymphoma
Pharmaceutical Preparations
Maximum Tolerated Dose
Neutropenia
Hodgkin Disease
3 Citations (Scopus)

CNS relapse in patients with DLBCL treated with lenalidomide plus R-CHOP (R2CHOP): Analysis from two phase 2 studies

Ayed, A. O., Chiappella, A., Pederson, L., Laplant, B. R., Congiu, A. G., Gaidano, G., Spina, M., Re, A., Cavallo, F., Musuraca, G., MacOn, W. R., Witzig, T. E., Vitolo, U. & Nowakowski, G. S., Jul 1 2018, In : Blood Cancer Journal. 8, 7, 63.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Central Nervous System
Recurrence
lenalidomide
8 Citations (Scopus)

Diagnosis-to-treatment interval is an important clinical factor in newly diagnosed diffuse large B-cell lymphoma and has implication for bias in clinical trials

Maurer, M. J., Ghesquières, H., Link, B. K., Jais, J. P., Habermann, T. M., Thompson, C. A., Haioun, C., Allmer, C., Johnston, P. B., Delarue, R., Micallef, I., Peyrade, F., Inwards, D. J., Ketterer, N., Farooq, U., Fitoussi, O., Macon, W. R., Molina, T. J., Syrbu, S., Feldman, A. L. & 8 othersSlager, S. L., Weiner, G. J., Ansell, S. M., Cerhan, J. R., Salles, G. A., Witzig, T. E., Tilly, H. & Nowakowski, G. S., Jun 1 2018, In : Journal of Clinical Oncology. 36, 16, p. 1603-1610 8 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Clinical Trials
Lymphoma
Therapeutics
Selection Bias